Apex Medical, Inc.
Apex Medical, Inc., a leading name in the healthcare industry, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1990, the company has established itself as a pioneer in the development of innovative medical devices and solutions, particularly in the fields of sleep therapy and respiratory care. Apex Medical is renowned for its high-quality products, including CPAP devices and accessories, which are designed to enhance patient comfort and compliance. The company’s commitment to research and development has led to significant advancements in technology, setting it apart from competitors. With a strong market presence and a reputation for excellence, Apex Medical continues to achieve notable milestones, solidifying its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Apex Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apex Medical, Inc.'s score of 19 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apex Medical, Inc.'s reported carbon emissions
In 2022, Apex Medical, Inc. reported total carbon emissions of approximately 48,000,000 kg CO2e across all scopes. This includes 3,482,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling, amounted to about 750,000 kg CO2e (market-based) and 1,834,000 kg CO2e (location-based). The majority of emissions stem from Scope 3, which totalled approximately 40,187,445,000 kg CO2e. Significant contributors within Scope 3 include purchased goods and services (about 40,187,445,000 kg CO2e), upstream transportation and distribution (approximately 2,165,341,000 kg CO2e), and downstream transportation and distribution (around 8,739,141,000 kg CO2e). Currently, Apex Medical, Inc. has not set specific reduction targets or climate pledges, nor do they have any initiatives reported through the Science Based Targets initiative (SBTi). The company does not inherit emissions data from a parent or related organization, indicating that all reported figures are independently sourced. Apex Medical, Inc. is committed to addressing its carbon footprint, but further details on specific reduction strategies or future commitments are not available at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 3,482,000 |
| Scope 2 | 750,000 |
| Scope 3 | 54,453,320,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apex Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
